We are live on ! Find out more
UTMD icon

Utah Medical Products
UTMD

74 hedge funds and large institutions have $182M invested in Utah Medical Products in 2017 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 35 increasing their positions, 22 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

59% more repeat investments, than reductions

Existing positions increased: 35 | Existing positions reduced: 22

2% more capital invested

Capital invested by funds: $179M → $182M (+$3.13M)

0.08% more ownership

Funds ownership: 66.6% → 66.68% (+0.08%)

3% less funds holding

Funds holding: 76 → 74 (-2)

50% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 4

Holders
74
Holders Change
-2
Holders Change %
-2.63%
% of All Funds
1.84%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
35
Reduced
22
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
+$1.92M
2
Vanguard Group
Vanguard Group
Pennsylvania
+$1.43M
3
Fidelity Investments
Fidelity Investments
Massachusetts
+$1.1M
4
OAM
Oxford Asset Management
United Kingdom
+$726K
5
State Street
State Street
Massachusetts
+$676K

Top Sellers

Rank Fund Capital Flow
1
American Century Companies
American Century Companies
Missouri
-$6.72M
2
BCM
Bridgeway Capital Management
Texas
-$432K
3
Millennium Management
Millennium Management
New York
-$358K
4
SEI Investments
SEI Investments
Pennsylvania
-$347K
5
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$316K
Name Holding Trade Value Shares
Change 		Change in
Stake
ACM
26
Ativo Capital Management
Illinois
$1.22M – – –
OAM
27
Oxford Asset Management
United Kingdom
$1.03M +$726K +10,100 +274%
US Bancorp
28
US Bancorp
Minnesota
$897K -$30.9K -430 -3%
NFA
29
Nationwide Fund Advisors
Ohio
$888K +$309K +4,300 +55%
IP
30
Isthmus Partners
Wisconsin
$801K +$10.1K +141 +1%
Millennium Management
31
Millennium Management
New York
$774K -$358K -4,975 -32%
CCMINC
32
Cardinal Capital Management Inc (North Carolina)
North Carolina
$732K +$56.2K +782 +9%
TCIM
33
TIAA CREF Investment Management
New York
$681K -$30.5K -424 -4%
UBS Group
34
UBS Group
Switzerland
$620K -$84.5K -1,175 -12%
Two Sigma Investments
35
Two Sigma Investments
New York
$605K +$132K +1,840 +29%
Charles Schwab
36
Charles Schwab
California
$567K – – –
Bessemer Group
37
Bessemer Group
New Jersey
$566K +$223K +3,100 +67%
SCP
38
Seizert Capital Partners
Michigan
$479K – – –
TA
39
Teachers Advisors
New York
$437K +$16.5K +230 +4%
Janney Montgomery Scott
40
Janney Montgomery Scott
Pennsylvania
$432K +$138K +1,920 +49%
California State Teachers Retirement System (CalSTRS)
41
California State Teachers Retirement System (CalSTRS)
California
$401K -$40.1K -558 -9%
TA
42
Teton Advisors
New York
$368K – – –
WCM
43
Wedge Capital Management
North Carolina
$360K – – –
SIM
44
Spark Investment Management
New York
$330K – – –
New York State Common Retirement Fund
45
New York State Common Retirement Fund
New York
$294K – – –
PIM
46
Penobscot Investment Management
Massachusetts
$294K – – –
RHJA
47
Rice Hall James & Associates
California
$282K +$144 +2 +0.1%
RhumbLine Advisers
48
RhumbLine Advisers
Massachusetts
$280K -$5.03K -70 -2%
FQ
49
First Quadrant
California
$275K -$104K -1,453 -28%
CI
50
Cigna Investments
Connecticut
$275K – – –
1
2
3 4

UTMD Hedge Fund Activity: Q3 2017 in Review

74 of the 4,012 institutional investors tracked by Wall St. Rank reported a position in Utah Medical Products (UTMD) for Q3 2017, worth a combined $182M — up 1.7% from $179M a quarter earlier.

Sellers outnumbered buyers: 4 funds closed out of UTMD and 2 opened new positions — a net loss of 2 holders — while 22 trimmed existing stakes and 35 added.

The largest buyer was Renaissance Technologies, adding an estimated $1.92M. The largest seller was American Century Companies, cutting an estimated $6.72M.

  • 74 institutional investors held Utah Medical Products (UTMD) as of Q3 2017, down from 76 in Q2 2017.
  • Funds reported $182M of Utah Medical Products stock for Q3 2017, up 1.7% quarter-over-quarter.
  • 2 funds opened new Utah Medical Products positions in Q3 2017 and 4 closed out, a net change of -2 holders.
  • The largest Utah Medical Products buyer in Q3 2017 was Renaissance Technologies, an estimated $1.92M added.
  • The largest Utah Medical Products seller in Q3 2017 was American Century Companies, an estimated $6.72M sold.

Based on aggregated 13F filings for Q3 2017.